| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/19/2008 | CA2672631A1 Benzamide derivatives as ep4 receptor agonists |
| 06/19/2008 | CA2672617A1 Novel 2-imidazoles as ligands for trace amine associated receptors (taar) |
| 06/19/2008 | CA2672596A1 Compositions and methods of using (r)-pramipexole |
| 06/19/2008 | CA2672524A1 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor |
| 06/19/2008 | CA2672494A1 Use of d-serine derivatives for the treatment of anxiety disorders |
| 06/19/2008 | CA2672464A1 Dihydrobenzofuranyl derivatives and methods of their use |
| 06/19/2008 | CA2672462A1 Ampa receptor potentiators |
| 06/19/2008 | CA2672293A1 Aspartyl protease inhibitors |
| 06/19/2008 | CA2672187A1 Acetylene derivatives and their use for binding and imaging amyloid plaques |
| 06/19/2008 | CA2672176A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | CA2671980A1 Quinoxaline derivatives |
| 06/19/2008 | CA2671891A1 V3 antagonists for the treatment or prevention of chronic pain |
| 06/19/2008 | CA2671683A1 Pharmaceutical compositions and their methods of use |
| 06/19/2008 | CA2670054A1 Selective inhibitors of neurotensin degrading enzymes |
| 06/18/2008 | EP1931695A1 Prion-specific peptoid reagents |
| 06/18/2008 | EP1931683A1 Fused tricyclic mglur1 antagonists as therapeutic agents |
| 06/18/2008 | EP1931680A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 06/18/2008 | EP1931678A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics |
| 06/18/2008 | EP1931676A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 06/18/2008 | EP1931674A2 Deazapurines useful as inhibitors of janus kinases |
| 06/18/2008 | EP1931669A1 Kinase inhibitors |
| 06/18/2008 | EP1931668A2 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 06/18/2008 | EP1931664A2 Methods of modulating neurotrophin-mediated activity |
| 06/18/2008 | EP1931661A1 Isoxazolo derivatives as gaba a alpha5 inverse agonists |
| 06/18/2008 | EP1931656A1 Novel drugs for dementia |
| 06/18/2008 | EP1931653A2 Therapeutic pyrrolidines |
| 06/18/2008 | EP1931640A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 06/18/2008 | EP1931637A2 Methods of modulating neurotrophin-mediated activity |
| 06/18/2008 | EP1931635A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 06/18/2008 | EP1931631A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/18/2008 | EP1931341A2 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxalase tyrosine inducers |
| 06/18/2008 | EP1931336A1 Tetrahydro-indazolyl cannabinoid modulators |
| 06/18/2008 | EP1931335A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 06/18/2008 | EP1675853B1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 06/18/2008 | EP1617839B1 The use of azetidinecarboxamide derivatives in therapy |
| 06/18/2008 | EP1594861B1 Triazole compounds and the therapeutic use thereof |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 06/18/2008 | EP1232160B1 Spiro(2h-1-benzopyran-2,4'-piperidine)derivates as glycine transport inhibitors |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/18/2008 | CN101203511A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/18/2008 | CN101203505A Chromane and chromene derivatives and uses thereof |
| 06/18/2008 | CN101203501A Dihydrobenzofuranyl alkanamine derivatives as 5HT2C agonists |
| 06/18/2008 | CN101203493A Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 06/18/2008 | CN101203492A Substituted butyrophenone derivatives |
| 06/18/2008 | CN101203242A Method for treating dementia or alzheimer's disease by CD2O antibody |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/18/2008 | CN101203218A Benzofuranyl alkanamine derivatives and uses as 5-HT2C excitant thereof |
| 06/18/2008 | CN101203216A Dihydrobenzofuran derivatives and uses thereof |
| 06/18/2008 | CN101200465A Decahydronaphthalene compounds and medical uses thereof |
| 06/18/2008 | CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 06/18/2008 | CN101199830A Heat-transfer dose medicament for treating migraine |
| 06/18/2008 | CN101199824A Claming capsule and preparing method thereof |
| 06/18/2008 | CN101199819A Medicament compound for treating Parkinson syndrome |
| 06/18/2008 | CN101199773A Compound essential oil of refreshing thinker |
| 06/18/2008 | CN101199768A Medicament compound treating brain shrink and senile dementia |
| 06/18/2008 | CN101199766A Medicament for treating epileps |
| 06/18/2008 | CN101199735A Medicament compound for treating children ADHD and preparing method thereof |
| 06/18/2008 | CN101199718A Female protected kidney capsule |
| 06/18/2008 | CN101199701A Chinese medicine for treating insomnia and preparing method thereof |
| 06/18/2008 | CN101199637A Chinese medicine decoction for oral administration for treating typhoid headachy |
| 06/18/2008 | CN101199622A Compound essential oil of adjusting sentiment, increasing wishes aphrodisiac |
| 06/18/2008 | CN101199609A Chinese medicine external treatment method of chemo-treatment medicament surrounding nerve toxic |
| 06/18/2008 | CN101199598A Extractive method of priceless rehabilitation effect active ingredients and products thereof |
| 06/18/2008 | CN101199554A Oil-soluble propolis soft capsule and preparing method thereof |
| 06/18/2008 | CN101199543A Compound for medicine by protogen and cobalamin activity component, preparing method and function thereof |
| 06/18/2008 | CN101199541A Zidovudine capsule and preparing method thereof |
| 06/18/2008 | CN101199538A Fructose two-phosphoric acid Na capsule and preparing method thereof |
| 06/18/2008 | CN101199537A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199534A Anti-tumor function of raw panoxadiol derivative |
| 06/18/2008 | CN101199532A Methanesulfonic acid reboxetine controlled-release capsule and preparing method thereof |
| 06/18/2008 | CN101199512A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
| 06/18/2008 | CN101199495A Patch of abstention containing cola stationary medicament and preparing method thereof |
| 06/18/2008 | CN101199348A Composite marrow medicinal granule and its preparation method |
| 06/18/2008 | CN100395245C Microcrystal |
| 06/18/2008 | CN100395237C 2,5-substituted tetrahydroisoquinolines for use as 5-HT6 modulators |
| 06/18/2008 | CN100395236C Piperazine and piperidine derivatives for treatment of neurological diseases |
| 06/18/2008 | CN100394979C Use of composition in preparing medicament for preventing and treating lethargy |
| 06/18/2008 | CN100394976C Chinese medicine for withdrawal of drug dependence |
| 06/18/2008 | CN100394957C Traditional Chinese medicine applied externally for treating epilepsy |
| 06/18/2008 | CN100394933C Application of 'Guizhi Gancao Longgu Muli' preparation in preparation of medicine for preventing and treating depression |
| 06/18/2008 | CN100394929C Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method |
| 06/17/2008 | US7388118 Amine 1,2- and 1,3-diol compounds |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388075 Medicament containing activated antithrombin III |
| 06/17/2008 | US7388022 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds |
| 06/17/2008 | US7388020 Compounds for chronic obstructive pulminary disorders for breathingand respiratory system diorders |
| 06/17/2008 | US7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 06/17/2008 | US7387879 Diagnosis of tauopathies |
| 06/17/2008 | US7387792 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/17/2008 | US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 06/17/2008 | CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders |
| 06/17/2008 | CA2467356C Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 06/17/2008 | CA2444053C Fused bicyclic or tricyclic amino acids |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2414063C Highly concentrated stable meloxicam solutions |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |